Drug Trial Radar · NCT05275465
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Apr 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
May 3, 2022
Primary completion
Dec 29, 2022
Study completion Dec 29, 2022
Sponsor
- Lead sponsor
- Huahui HealthIndustry
- Sponsor type
- Industry
- First posted
- Mar 11, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Huahui Health is developing a treatment for Hepatitis B virus. This study is designed to evaluate the safety and tolerability of HH-006, a hepatitis virus neutralizing monoclonal antibody in healthy volunteers, and to determine its pharmacokinetic profile and immunogenicity.
Conditions
- Hepatitis B
Interventions
HH-006Drug
Different dose levels of HH-006
PlaceboDrug
Different dose levels of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment emergent adverse events (TEAEs)Time frame: Day 1- Day 113
- Severity of treatment emergent adverse events as measured by CTCAE v 5.0Time frame: Day 1- Day 113
- Duration of treatment emergent adverse eventsTime frame: Day 1- Day 113
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Q-Pharm Pty Ltd (Nucleus Network Pty Ltd)
Brisbane, Queensland, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.